Prednisone for Decompensated Congestive Heart Failure
Chronic Administration of Prednisone in Management of Patients With Decompensated Congestive Heart Failure
Sponsor: Hebei Medical University
Suspended
This trial was suspended. No reason was provided.
Listed as NCT00369044, this PHASE2/PHASE3 trial focuses on Heart Failure, Congestive and remains suspended. Sponsored by Hebei Medical University, it has been updated 5 times since 2006, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Suspended PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Suspended PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Suspended PHASE2_PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Suspended PHASE2_PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Suspended PHASE2_PHASE3
First recorded
Oct 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hebei Medical University
For direct contact, visit the study record on ClinicalTrials.gov .